NCT00452413 2021-05-13A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerEli Lilly and CompanyPhase 1/2 Completed65 enrolled 18 charts
NCT00402116 2020-08-06Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) PatientsEli Lilly and CompanyPhase 1/2 Completed72 enrolled 19 charts